Were you looking for information about Synagis? Synagus is a common misspelling of Synagis.
By binding to respiratory syncytial virus (RSV), Synagis® (palivizumab) can help prevent the virus from multiplying. Although this drug does not prevent an RSV infection, it can prevent the infection from becoming severe enough to cause serious complications in infants and children who have a high risk for problems.
This medication is given as an injection once a month during the RSV season, which is usually from November to April. Side effects may include fever, ear infections, and a runny nose.
(For more information on this medicine, click Synagis. This full-length article offers a complete overview of this medication, including how it works, when it is used, and general dosing guidelines. You can also click any of the links in the box to the right for specific information.)
HealthSavvy Sign In
|